StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health Unrealized Loss Position (< 12 Months) by Quarter

Unrealized Loss Position (< 12 Months) — Gross Unrealized Loss ($M)

QuarterlyAnnual

Elevance Health Unrealized Loss Position (< 12 Months): $1,013M in Q3 2026, up 667.4% from a year earlier.

Latest, Q3 2026
1,013
Period ended Sep 30, 2026
Change on a year earlier
+667.4%
132 in Q3 2025
History
13 quarters
Since Q4 2022
Sources
2
Documents cited below

Where the Q3 2026 figure comes from

“us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss (2026-09-30): 1,013,000,000.00”

Source: ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedUnrealized Loss Position (< 12 Months) — Gross Unrealized Loss ($M)Year on yearSource
Q3 2026Sep 30, 20261,013+667.4%ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗
Q2 2026Jun 30, 2026152+18.8%ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗
Q1 2026Mar 31, 2026170+34.9%ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗
Q4 2025Dec 31, 202571-67.4%ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗
Q3 2025Sep 30, 2025132+633.3%ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗
Q2 2025Jun 30, 2025128-7.2%ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗
Q1 2025Mar 31, 2025126+26.0%ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗
Q4 2024Dec 31, 2024218+296.4%ELV 10-K (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗
Q3 2024Sep 30, 202418–ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗
Q2 2024Jun 30, 2024138–ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗
Q1 2024Mar 31, 2024100–ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗
Q4 2023Dec 31, 202355-94.9%ELV 10-K (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗
Q4 2022Dec 31, 20221,071–ELV 10-K (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗

Cite this data

StockData. (2026). Elevance Health Unrealized Loss Position (< 12 Months) ($M), quarterly Q4 2022–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv-loss-pos-lt12m-loss

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.